JAGX - Jaguar Health, Inc.
0.16 0.00 (1.25%)
After hours: 6:12PM EDT
| Previous Close | 0.16 |
| Open | 0.16 |
| Bid | 0.15 x 4000 |
| Ask | 0.16 x 1800 |
| Day's Range | 0.14 - 0.16 |
| 52 Week Range | 0.10 - 0.99 |
| Volume | 3,016,721 |
| Avg. Volume | 10,368,398 |
| Market Cap | 27.256M |
| Beta | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.51 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.25 |
- ACCESSWIRE•7 days ago
Experts Highlight that Immune System Activation in Aging Patients Living with HIV/AIDS Triggers Effects Such as "Leaky Gut", Which Can Lead to Diarrhea
Mytesi for HIV-related Diarrhea Now on ADAP Formularies in 22 States SAN FRANCISCO, CA / ACCESSWIRE / April 19, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), ...
- ACCESSWIRE•16 days ago
Jaguar Subsidiary Napo Pharmaceuticals Signs Agreement with the ADAP Crisis Task Force for Mytesi
Agreement Provides Pricing for Mytesi to Each U.S. State's AIDS Drug Assistance Program (ADAP) - Organizations that Provide HIV-related Services and Approved Medications to More than Half a Million People ...
- ACCESSWIRE•24 days ago
Jaguar Health Appoints Jonathan B. Siegel to Board of Directors
SAN FRANCISCO, CA / ACCESSWIRE / April 2, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage natural-products pharmaceutical company focused on ...
- ACCESSWIRE•last month
Jaguar Health Announces Up to $16.2 Million in Equity Financings in Separate Private Placement Investments, Including Investment by Sagard Capital Partners, L.P., to Continue Commercialization of FDA-Approved Mytesi
Largest Investor Locked in for 12 Months SAN FRANCISCO, CA / ACCESSWIRE / March 26, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage natural-products ...
- Simply Wall St.•last month
Why Jaguar Health Inc’s (NASDAQ:JAGX) CEO Pay Matters To You
Leading Jaguar Health Inc (NASDAQ:JAGX) as the CEO, Lisa Conte took the company to a valuation of US$32.95M. Understanding how CEOs are incentivised to run and grow their company isRead More...
- Business Wire•last month
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Jaguar Health, Inc.
Levi & Korsinsky announces it has commenced an investigation of Jaguar Health, Inc. concerning possible breaches of fiduciary duty. To obtain additional informat
- ACCESSWIRE•last month
Jaguar Health, Pipeline Review, Analyst Ratings, Milestones
NEW YORK, NY / ACCESSWIRE / March 13, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
- ACCESSWIRE•2 months ago
Today’s Research Reports on Stocks to Watch: Atossa Genetics and Jaguar Health
NEW YORK, NY / ACCESSWIRE / March 9, 2018 / Shares of Atossa ended in the green on Thursday but fell deep into the red in after-hours trading when it announced its financial report for 2017. Shares of ...
- ACCESSWIRE•2 months ago
FDA Indicates that Jaguar's Reasonable Expectation of Effectiveness Technical Section is Complete for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs
SAN FRANCISCO, CA / ACCESSWIRE / March 8, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably ...
- GlobeNewswire•2 months ago
Report: Developing Opportunities within TripAdvisor, Glu Mobile, KeyCorp, SMART SAND INC, Jaguar Animal Health, and Cleveland-Cliffs — Future Expectations, Projections Moving into 2018
NEW YORK, March 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- ACCESSWIRE•2 months ago
Jaguar Health Subsidiary, Napo Pharmaceuticals, Signs Agreement with Pharmacy Services Provider "Transition Patient Services" to Establish Nationwide Pilot "Mytesi Direct" Program
SAN FRANCISCO, CA / ACCESSWIRE / March 2, 2018 / Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably ...
- Simply Wall St.•2 months ago
How Financially Strong Is Jaguar Health Inc (NASDAQ:JAGX)?
Investors are always looking for growth in small-cap stocks like Jaguar Health Inc (NASDAQ:JAGX), with a market cap of US$17.48M. However, an important fact which most ignore is: how financiallyRead More...
- Business Wire•3 months ago
Jaguar Health Provides Updates Regarding Commercial, Educational & Product Development Programs and 2017 Results for Mytesi Since Merger (August–December 2017)
Jaguar Health, Inc. , a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, today provided the following updates regarding commercial, educational and product development programs and 2017 results.
- Business Wire•3 months ago
Jaguar Health to Host Conference Call Monday, January 22nd at 4:15 p.m. Eastern Time to Provide Updates Regarding Jaguar and Napo Pharmaceuticals Commercial, Educational & Product Development Activities and 2017 Results
Jaguar Health, Inc. , a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, announced today that Company management will host a conference call on Monday, January 22, 2018 at 4:15 p.m.
- Business Wire•3 months ago
Napo Pharmaceuticals Comments on the Passing of HIV/AIDS Activist and Research Pioneer Dr. Mathilde Krim
Napo Pharmaceuticals, Inc. , a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc.
- Simply Wall St.•4 months ago
Jaguar Health Inc (NASDAQ:JAGX): Has Recent Earnings Growth Beaten Long-Term Trend?
Assessing Jaguar Health Inc’s (NASDAQ:JAGX) past track record of performance is a valuable exercise for investors. It enables us to reflect on whether the company has met or exceed expectations,Read More...
- ACCESSWIRE•4 months ago
WallStreet Research(TM) Announces Release of Corporate Profile Coverage on Jaguar Health, Inc. (NASDAQ: JAGX)
NEW YORK, NY / ACCESSWIRE / December 26, 2017 / WallStreet Research™ (WSR), a top-ranked independent research firm with a history spanning over three decades, today announced that it has initiated Corporate ...
- Business Wire•4 months ago
Jaguar Health and Dubai-based Seed Mena Enter Collaboration Agreement for Equilevia, Jaguar’s Personalized, Premium Product for Total Gut Health and Wellness in Horses
Jaguar Health, Inc. , a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, announced today that it has entered into a collaboration agreement with Seed Mena Businessmen Services LLC for Equilevia™, Jaguar’s non-prescription, personalized, premium product ...
- Business Wire•4 months ago
New Survey Finds People Living With HIV With Diarrhea Often Suffer in Silence
Napo Pharmaceuticals, Inc. , a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc.
- Business Wire•5 months ago
Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Friday, December 15, 2017
Jaguar Health, Inc. , a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, announced today that its Special Meeting of Stockholders scheduled for and convened on December 1, 2017 , was adjourned to achieve a quorum on the proposals set forth in Jaguar's definitive ...
- Business Wire•5 months ago
Keep Your Pants On Campaign From Napo Pharmaceuticals Chosen as Best HIV-Related Awareness Campaign of 2017 by Healthline
Napo Pharmaceuticals, Inc. , a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc.
- Simply Wall St.•5 months ago
What You Must Know About Jaguar Health Inc’s (JAGX) Financial Strength
Investors are always looking for growth in small-cap stocks like Jaguar Health Inc (NASDAQ:JAGX), with a market cap of USD $14.95M. However, an important fact which most ignore is: howRead More...
- Business Wire•5 months ago
Jaguar Health Enters Share Purchase Agreement for 2 Million Shares and Common Stock Purchase Agreement Relating to a 10 Million Share Equity Line Offering With L2 Capital, LLC
Jaguar Health, Inc. , a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, announced today that, on November 24, 2017, the Company entered into a Share Purchase Agreement with L2 Capital, LLC, a Kansas limited liability company , pursuant to which Jaguar sold ...
- Business Wire•5 months ago
Jaguar Health Files First Quarterly Earnings Report Since July 2017 Merger with Napo Pharmaceuticals
Jaguar Health, Inc. , a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis, announced that the Company filed its first quarterly earnings report today since the merger between Jaguar Animal Health and Napo Pharmaceuticals became effective on July 31, 2017.
